Elevated plasma TGF-β1 in renal diseases: Cause or consequence?

Cytokine

Volumn 12, Issue 7, 2000, Pages 1084-1091

  Junker, U ^a   Haufe, C C ^a   Nuske, K ^a   Rebstock, K ^b   Steiner, T ^a   Wunderlich, H ^a   Junker, K ^a   Reinhold, D ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Thueringen Krankhs Saalfeld A   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Common variable immunodeficiency; Dialysis; Kidney transplantation; Lung cancer; Renal cell carcinoma; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD LEVEL; CANCER SURGERY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXTRACORPOREAL LITHOTRIPSY; HUMAN; HUMORAL IMMUNE DEFICIENCY; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PYELONEPHRITIS;

EID: 0033911180     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0645     Document Type: Article

References (21)

1. Reinhold D, Bank U, Bühling F, Lendeckel U, Ulmer AJ, Flad HD, Ansorge S (1994) Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 6:382-388.
2. Reinhold D, Bank U, Bühling F, Lendeckel U, Ansorge S (1995) Transforming growth factor β1 inhibits Interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells. J Interferon Cytokine Res 15:685-690.
3. Knoefel B, Nuske K, Steiner T, Junker K, Kosmehl H, Rebstock K, Reinhold D, Junker U (1997) Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta-a in primary cultures and modulate lymphocyte blast transformation. J Interferon Cytokine Res 17:95-102.
4. Bergh J (1988) The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors. Am J Pathol 133:434-439.
5. Mizukami Y, Nonomura A, Yamada T, Kurumaya H, Hayashi M, Koyasaki N, Taniya T, Noguchi M, Nakamura S, Matsubara F (1990) Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues. Anticancer Res 10:1115-1126.
6. Junker U, Knöfel B, Nuske K, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (1996) Transforming growth factor β1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8:794-798.
7. Wunderlich H, Steiner T, Junker U, Knoefel B, Schlichter B, Schubert J (1997) Serum transforming growth factor-beta-1 in patients with renal cell carcinoma. J Urol 157:1602-1603.
8. Shim KS, Kim KH, Han WS, Park EB (1999) Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and ist significant decrease after curative surgical resection. Cancer 85:554-561.
9. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S, Sugimachi K (1999) Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607-614.
10. Lee WJ, Chang KJ, Lee CS, Chen KM (1994) Selective depression of T-lymphocyte subsets in gastric cancer patients: an implication of immunotherapy. J Surg Oncol 55:165-169.
11. Lanning DA, Nwomeh BC, Montante SJ, Yager DR, Diegelmann RF, Haynes JH (1999) TGF-beta1 alters the healing of cutaneous fetal excisional wounds. J Pediatr Surg 34:695-700.
12. Schini-Kerth VB, Bassus S, Fisslthaler B, Kirchmaier CM, Busse R (1997) Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factor AB. Circulation 96:3888-3896.
13. Iwano M, Akai Y, Fujii Y, Dohi Y, Matsumura N, Dohi K (1994) Intraglomerular expression of transforming growth factor-β1 (TGF-β1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol 97:309-314.
14. Dominguez GCS, Costa RS, Dantas M, Kimachi T, Coimbra TM (1995) Transforming growth factor β (TGF beta) activity in urine of patients with glomerulonephritis. Braz J Med Biol Res 1995:1061-1064.
15. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS (1995) Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576.
16. Phillips AO, Steadman R, Topley N, Williams JD (1995) Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells: the permissive role of platelet-derived growth factor. Am J Pathol 147:362-374.
17. Hoffman BB, Sharma K, Ziyadeh FN (1998) Potential role of TGF-β in diabetic nephropathy. Miner Electrolyte Metab 24: 190-196.
18. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS (1996) Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003.
19. Danielpour D (1993) Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta-1. J Immunol Meth 158:17-25.
20. Reinhold D, Bank U, Buehling F, Junker U, Kekow J, Schleicher E, Ansorge S (1997) Letter to the editors: a detailed protocol for the measurement of TGF-beta-1 in human blood samples. J Immunol Meth 209:203-206.
21. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA, et al. (1995) Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1:129-136.